In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

CRISPR Therapeutics AG. Trade Record

NASDAQ:CRSP CRISPR Therapeutics AG stock gains 7.50% Exit Jan 22, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart CRSP Jan 4, 2019, priceSeries
About CRISPR Therapeutics AG

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.

Trade Information
Trade Type
Entry Date
Jan 4, 2019
Entry Price
Sell Date
Jan 22, 2019
Sell Price
Net Gain
Hold Time
11 Trading Days